Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-03

Clinical Trial Update: Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications [Phase 4]

View source ↗

Summary

Phase 4 trial investigating preventive effects of penehyclidine hydrochloride inhalation on postoperative pulmonary complications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penehyclidine hydrochloride (penehyclidine hydrochloride)

Snippet

Sponsor: Peking University First Hospital | Conditions: Postoperative Complications | Phase 4 | Status: COMPLETED